Cargando…
The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel
Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common ind...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857389/ https://www.ncbi.nlm.nih.gov/pubmed/36673130 http://dx.doi.org/10.3390/diagnostics13020320 |
_version_ | 1784873857393360896 |
---|---|
author | Gentile, Ivan Schiano Moriello, Nicola Hopstaken, Rogier Llor, Carl Melbye, Hasse Senn, Oliver |
author_facet | Gentile, Ivan Schiano Moriello, Nicola Hopstaken, Rogier Llor, Carl Melbye, Hasse Senn, Oliver |
author_sort | Gentile, Ivan |
collection | PubMed |
description | Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common indications for their prescription. An expert panel conducted an extensive report on C-reactive protein point-of-care (CRP POC) testing in the evaluation of LRTIs and its usefulness to limit antibiotic prescriptions. The expert panel stated that CRP POC testing is a potentially useful tool to limit antibiotic prescriptions for LRTI in a community setting. CRP POC must be used in conjunction with other strategies such as improved communication skills and the use of other molecular POC testing. Potential barriers to the adoption of CRP POC testing are financial and logistical issues. Moreover, the efficacy in limiting antibiotic prescriptions could be hampered by the fact that, in some countries, patients may gain access to antibiotics even without a prescription. Through the realization of a better reimbursement structure, the inclusion in standardized procedures in local guidelines, and better patient education, CRP point-of-care testing can represent a cornerstone in the fight against antimicrobial resistance. |
format | Online Article Text |
id | pubmed-9857389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98573892023-01-21 The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel Gentile, Ivan Schiano Moriello, Nicola Hopstaken, Rogier Llor, Carl Melbye, Hasse Senn, Oliver Diagnostics (Basel) Article Tackling antibiotic resistance represents one of the major challenges in modern medicine, and limiting antibiotics’ overuse represents the first step in this fight. Most antibiotics are prescribed in primary care settings, and lower respiratory tract infections (LRTIs) are one of the most common indications for their prescription. An expert panel conducted an extensive report on C-reactive protein point-of-care (CRP POC) testing in the evaluation of LRTIs and its usefulness to limit antibiotic prescriptions. The expert panel stated that CRP POC testing is a potentially useful tool to limit antibiotic prescriptions for LRTI in a community setting. CRP POC must be used in conjunction with other strategies such as improved communication skills and the use of other molecular POC testing. Potential barriers to the adoption of CRP POC testing are financial and logistical issues. Moreover, the efficacy in limiting antibiotic prescriptions could be hampered by the fact that, in some countries, patients may gain access to antibiotics even without a prescription. Through the realization of a better reimbursement structure, the inclusion in standardized procedures in local guidelines, and better patient education, CRP point-of-care testing can represent a cornerstone in the fight against antimicrobial resistance. MDPI 2023-01-15 /pmc/articles/PMC9857389/ /pubmed/36673130 http://dx.doi.org/10.3390/diagnostics13020320 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gentile, Ivan Schiano Moriello, Nicola Hopstaken, Rogier Llor, Carl Melbye, Hasse Senn, Oliver The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title | The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title_full | The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title_fullStr | The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title_full_unstemmed | The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title_short | The Role of CRP POC Testing in the Fight against Antibiotic Overuse in European Primary Care: Recommendations from a European Expert Panel |
title_sort | role of crp poc testing in the fight against antibiotic overuse in european primary care: recommendations from a european expert panel |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857389/ https://www.ncbi.nlm.nih.gov/pubmed/36673130 http://dx.doi.org/10.3390/diagnostics13020320 |
work_keys_str_mv | AT gentileivan theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT schianomoriellonicola theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT hopstakenrogier theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT llorcarl theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT melbyehasse theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT sennoliver theroleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT gentileivan roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT schianomoriellonicola roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT hopstakenrogier roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT llorcarl roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT melbyehasse roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel AT sennoliver roleofcrppoctestinginthefightagainstantibioticoveruseineuropeanprimarycarerecommendationsfromaeuropeanexpertpanel |